Develops allogeneic CAR‑iNKT cell therapies from hematopoietic stem cells to treat cancers, partnering with industry for clinical development.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2021
Create a free account to see which investors have funded this company.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
